| Literature DB >> 31802245 |
Xue Zhu1, Ke Wang1, Yan Jin2, Shuya Wang2, Xiaoxiao Liu2, Haohao Liu3, Peiling Zhou2, Chengjian Yang4, Zhijun Han5.
Abstract
Circulating microRNAs are of diagnostic value for acute myocardial infarction (AMI). This study describes a fluorometric assay for multiplexed detection of the AMI biomarkers microRNA-499, microRNA-133a and microRNA-1. The assay involves the following two steps: (a) duplex-specific nuclease (DSN)-mediated signal amplification using aptamer-based sensor; (b) MoS2 nanosheets-based multiplexed fluorometric signal detection, and fluorometric signals have excitation/emission maxima at 492/518 nm for microRNA-499, 565/580 nm for microRNA-133a and 649/663 nm for microRNA-1. The assay has detection limits of around 100 fM for all three microRNAs. The assay is highly specific and rapid. It demonstrates that the expressions of microRNA-499, microRNA-133a and microRNA-1 are significantly higher in AMI patients. The ROC curves allow a clear distinction to be made between AMI group and non-AMI group. Graphical abstractSchematic representation of a multiplexed fluorometric method based on duplex-specific nuclease (DSN)-mediated signal amplification and MoS2 nanosheets-based fluorometric signal detection (DSN-MoS2) for rapid, sensitive and specific detection of microRNAs in AMI.Entities:
Keywords: Acute myocardial infarction; Duplex-specific nuclease-mediated signal amplification; MicroRNA-1; MicroRNA-133a; MicroRNA-499; MoS2 nanosheets-based fluorometric signal detection; Quantitative real time-PCR
Mesh:
Substances:
Year: 2019 PMID: 31802245 DOI: 10.1007/s00604-019-3896-5
Source DB: PubMed Journal: Mikrochim Acta ISSN: 0026-3672 Impact factor: 5.833